Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2020

May 15, 2020

SELL
$8.89 - $24.94 $101,843 - $285,712
-11,456 Closed
0 $0
Q4 2019

Feb 12, 2020

BUY
$8.33 - $19.95 $95,428 - $228,547
11,456 New
11,456 $214,000
Q4 2017

Feb 14, 2018

SELL
$3.9 - $4.66 $82,972 - $99,141
-21,275 Closed
0 $0
Q3 2017

Nov 13, 2017

BUY
$4.14 - $5.12 $6,011 - $7,434
1,452 Added 7.32%
21,275 $93,000
Q2 2017

Aug 11, 2017

BUY
N/A
19,823
19,823 $93,000

Others Institutions Holding XBIT

About XBiotech Inc.


  • Ticker XBIT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 30,439,300
  • Market Cap $102M
  • Description
  • XBiotech Inc., a biopharmaceutical company, discovers, develops, and commercializes True Human monoclonal antibodies for treating various diseases. The company focuses on developing a pipeline of product candidates targeting both inflammatory and infectious diseases. It is also developing interleukin-1 alpha therapies to treat variety of medical...
More about XBIT
Track This Portfolio

Track Pro Share Advisors LLC Portfolio

Follow Pro Share Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pro Share Advisors LLC with notifications on news.